« back to the search result list  
PROPIONIC ANHYDRIDEICSC: 0558 (April 2024)
Propanoic anhydride
Methylacetic anhydride
Propanoic acid anhydride
CAS #: 123-62-6
UN #: 2496
EC Number: 204-638-2

  ACUTE HAZARDS PREVENTION FIRE FIGHTING
FIRE & EXPLOSION Combustible.  Above 63°C explosive vapour/air mixtures may be formed.  NO open flames.  Above 63°C use a closed system and ventilation.  Use water spray, powder, alcohol-resistant foam, carbon dioxide.   

 AVOID ALL CONTACT! PREVENT GENERATION OF MISTS!  
  SYMPTOMS PREVENTION FIRST AID
Inhalation Cough. Sore throat. Burning sensation. Shortness of breath. Symptoms may be delayed. See Notes.  Use ventilation, local exhaust or breathing protection.  Fresh air, rest. Half-upright position. Artificial respiration may be needed. Refer immediately for medical attention. 
Skin Redness. Pain. Skin burns.  Protective gloves. Protective clothing.  Remove contaminated clothes. Rinse skin with plenty of water or shower. Refer immediately for medical attention . 
Eyes Redness. Pain. Severe burns.  Wear face shield or eye protection in combination with breathing protection.  Rinse with plenty of water for several minutes (remove contact lenses if easily possible). Refer immediately for medical attention. Keep rinsing during transport for medical attention. 
Ingestion Burns in mouth and throat. Abdominal pain. Shock or collapse.  Do not eat, drink, or smoke during work.  Rinse mouth. Do NOT induce vomiting. Give nothing to drink. Refer immediately for medical attention. 

SPILLAGE DISPOSAL CLASSIFICATION & LABELLING
Personal protection: chemical protection suit including self-contained breathing apparatus, face shield and protective gloves. Collect leaking liquid in sealable containers. Absorb remaining liquid in dry sand or inert absorbent. Then store and dispose of according to local regulations. 

According to UN GHS Criteria

corrcancer;health haz
DANGER
Causes severe skin burns and eye damage
May cause damage to lungs if inhaled
May cause damage to upper respiratory tract and lungs through prolonged or repeated exposure if inhaled 

Transportation
UN Classification
UN Hazard Class: 8; UN Pack Group: III 

STORAGE
Dry. Ventilation along the floor. Separated from bases, oxidants and food and feedstuffs. Store only in original container. 
PACKAGING
Do not transport with food and feedstuffs. 
PROPIONIC ANHYDRIDE ICSC: 0558
PHYSICAL & CHEMICAL INFORMATION

Physical State; Appearance
COLOURLESS LIQUID WITH PUNGENT ODOUR. 

Physical dangers
The vapour is heavier than air. 

Chemical dangers
Decomposes on contact with water. This produces corrosive propionic acid (see ICSC 0806). Reacts violently with bases and oxidants. This generates fire and explosion hazard. 

Formula: C6H10O3 / (CH3CH2CO)2O
Molecular mass: 130.2
Boiling point: 167°C
Melting point: -45°C
Relative density (water = 1): 1.01
Solubility in water: reaction
Vapour pressure, kPa at 20°C: 0.1
Relative vapour density (air = 1): 4.5
Relative density of the vapour/air-mixture at 20°C (air = 1): 4.4
Flash point: 63°C c.c.
Auto-ignition temperature: 285°C
Explosive limits, vol% in air: 1.3-9.5 


EXPOSURE & HEALTH EFFECTS

Routes of exposure
The substance can be absorbed into the body by inhalation and by ingestion. 

Effects of short-term exposure
The substance is corrosive to the eyes, skin and respiratory tract. Corrosive on ingestion. Inhalation of high concentrations may cause lung oedema, but only after initial corrosive effects on the eyes and the upper respiratory tract have become manifest. See Notes. 

Inhalation risk
No indication can be given about the rate at which a harmful concentration of this substance in the air is reached on evaporation at 20°C. 

Effects of long-term or repeated exposure
Repeated or chronic inhalation of the vapour may cause chronic inflammation of the upper respiratory tract. The substance may have effects on the lungs. This may result in bronchitis. 


OCCUPATIONAL EXPOSURE LIMITS
 

ENVIRONMENT
 

NOTES
The symptoms of lung oedema often do not become manifest until a few hours have passed and they are aggravated by physical effort. Rest and medical observation are therefore essential.
Immediate administration of an appropriate inhalation therapy by a doctor, or by an authorized person, should be considered. 

ADDITIONAL INFORMATION
  EC Classification
 

All rights reserved. The published material is being distributed without warranty of any kind, either expressed or implied. Neither ILO nor WHO nor the European Commission shall be responsible for the interpretation and use of the information contained in this material.